Lucid Diagnostics Stock Price on December 9, 2024
| LUCD Stock | USD 1.55 0.05 3.33% |
If you're considering investing in Lucid Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lucid Diagnostics stands at 1.55, as last reported on the 26th of March, with the highest price reaching 1.57 and the lowest price hitting 1.50 during the day. Lucid Diagnostics is dangerous given 3 months investment horizon. Lucid Diagnostics has Sharpe Ratio of 0.25, which conveys that the firm had a 0.25 % return per unit of risk over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.29% are justified by taking the suggested risk. Use Lucid Diagnostics Mean Deviation of 3.62, risk adjusted performance of 0.1926, and Downside Deviation of 4.86 to evaluate company specific risk that cannot be diversified away.
At present, Lucid Diagnostics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 32.3 B, whereas Common Stock Total Equity is forecasted to decline to about 32.8 K. . At present, Lucid Diagnostics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (0.0008). Lucid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lucid |
Sharpe Ratio = 0.2453
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LUCD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.24 actual daily | 46 54% of assets are more volatile |
Expected Return
| 1.29 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.25 actual daily | 19 81% of assets perform better |
Based on monthly moving average Lucid Diagnostics is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lucid Diagnostics by adding it to a well-diversified portfolio.
Price Book 2.159 | Enterprise Value Ebitda (0.67) | Price Sales 30.9469 | Shares Float 18.6 M | Wall Street Target Price 3.6667 |
Related Headline
Paragon 28 Headline on 9th of December 2024
Disposition of 14403 shares by Mvm Partners, Llc of Paragon ... by Mvm Partners, Llc
Filed transaction by Paragon 28 10 Percent Owner. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Lucid Diagnostics Valuation on December 9, 2024
It is possible to determine the worth of Lucid Diagnostics on a given historical date. On December 9, 2024 Lucid was worth 0.85 at the beginning of the trading date compared to the closed value of 0.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lucid Diagnostics stock. Still, in general, we apply an absolute valuation method to find Lucid Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lucid Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lucid Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 0.87 | 0.87 | 0.84 | 0.84 | 489,911 | |
12/09/2024 | 0.85 | 0.86 | 0.80 | 0.81 | 1,023,733 |
| 0.81 | 0.84 | 0.77 | 0.79 | 949,652 |
| Backtest Lucid Diagnostics | | | Lucid Diagnostics History | | | Lucid Diagnostics Valuation | Previous | Next |
Lucid Diagnostics Trading Date Momentum on December 9, 2024
| On December 10 2024 Lucid Diagnostics was traded for 0.79 at the closing time. The top price for the day was 0.84 and the lowest listed price was 0.77 . The trading volume for the day was 949.7 K. The trading history from December 10, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.47% . The trading delta at closing time against the current closing price is 1.23% . |
Lucid Diagnostics Fundamentals Correlations and Trends
By evaluating Lucid Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lucid Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lucid financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lucid Diagnostics Stock history
Lucid Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lucid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lucid Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lucid Diagnostics stock prices may prove useful in developing a viable investing in Lucid Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 50.5 M | 43.5 M | |
| Net Loss | -50.6 M | -48 M |
Lucid Diagnostics Stock Technical Analysis
Lucid Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lucid Diagnostics Period Price Range
Low | March 26, 2025
| High |
0.00 | 0.00 |
Lucid Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lucid Diagnostics March 26, 2025 Market Strength
Market strength indicators help investors to evaluate how Lucid Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lucid Diagnostics shares will generate the highest return on investment. By undertsting and applying Lucid Diagnostics stock market strength indicators, traders can identify Lucid Diagnostics entry and exit signals to maximize returns
Lucid Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lucid Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Lucid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lucid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1926 | |||
| Jensen Alpha | 1.1 | |||
| Total Risk Alpha | 1.09 | |||
| Sortino Ratio | 0.2265 | |||
| Treynor Ratio | 0.7229 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |